COVID context Like all trials, there are limitations. As mentioned, the number of infections here is small—the impressive efficacy numbers could potentially vanish in a larger trial with more infections. And, while the trial had a high-quality design, it was undertaken in just one location in Germany and mostly involved healthy white women between the ages of 20 and 46, …
Read More »OTC nasal spray seemed to cut COVID infections by 67% in mid-sized trial
